ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,033Medicare Part D Prescriptions Filled, Including Refills

Rank: 58 out of 1269

$674K Total Retail Price of All Prescriptions

Rank: 62 out of 1269

306 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 306 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 306 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 9,491 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
FUROSEMIDE 458 411 1 5
SIMVASTATIN 336 283 2 3
METOPROLOL TARTRATE 249 209 3 6
LEVOTHYROXINE SODIUM 241 206 4 4
AMLODIPINE BESYLATE 212 192 5 2
OMEPRAZOLE 188 167 6 8
LISINOPRIL 181 125 7 1
POTASSIUM CHLORIDE 180 167 8 26
METFORMIN HCL 171 152 9 9
ALLOPURINOL 159 132 10 49
CARVEDILOL 157 156 11 29
MIRTAZAPINE 154 139 12 24
LACTULOSE 150 137 13 67
NAMENDA 147 120 14 38
ISOSORBIDE MONONITRATE ER 145 137 15 63
ATENOLOL 144 131 16 14
GLIMEPIRIDE 140 116 17 57
WARFARIN SODIUM 136 100 18 12
TRAMADOL HCL 134 119 19 16
CLOPIDOGREL 130 129 20 32
RANITIDINE HCL 124 115 21 27
DONEPEZIL HCL 123 113 22 22
CLONIDINE HCL 120 89 23 51
METOPROLOL SUCCINATE 118 113 24 13
LOSARTAN POTASSIUM 115 108 25 15
FLUOXETINE HCL 108 88 26 83
HYDROCODONE-ACETAMINOPHEN 107 105 S3 27 20
TRAZODONE HCL 99 76 28 36
CIPROFLOXACIN HCL 97 85 29 66
RISPERIDONE 96 90 30 43
CITALOPRAM HBR 94 89 31 21
ADVAIR DISKUS 93 82 32 46
ATORVASTATIN CALCIUM 92 75 33 7
HYDRALAZINE HCL 91 74 34 48
DIVALPROEX SODIUM 84 84 35 54
ESCITALOPRAM OXALATE 83 83 36 58
PRAVASTATIN SODIUM 83 79 36 11
CARBIDOPA-LEVODOPA 80 55 38 78
PREDNISONE 79 78 39 45
TAMSULOSIN HCL 78 68 40 31
SPIRIVA 77 71 41 64
PLAVIX 77 77 41 47
METHADONE HCL 76 63 S2 43 165
GABAPENTIN 76 69 43 17
ALBUTEROL SULFATE 74 71 45 88
GLIPIZIDE 73 73 46 37
ALENDRONATE SODIUM 72 72 47 28
AZITHROMYCIN 72 64 47 42
FENTANYL 71 50 S2 49 105
POLYETHYLENE GLYCOL 3350 71 70 49 50
BENZTROPINE MESYLATE 67 33 R 51 108
QUETIAPINE FUMARATE 66 53 52 53
PANTOPRAZOLE SODIUM 65 61 53 18
CYMBALTA 64 58 54 70
IPRATROPIUM-ALBUTEROL 64 64 54 86
NYSTATIN 62 52 56 119
LANTUS 60 58 57 39
HYDROCHLOROTHIAZIDE 58 54 58 10
JANTOVEN 58 30 58 52
SINGULAIR 58 57 58 123
AMIODARONE HCL 53 48 61 166
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.